Sam Backenroth

2016 - Ohr Pharmaceutical

In 2016, Sam Backenroth earned a total compensation of $911.7K as Chief Financial Officer at Ohr Pharmaceutical, a 37% increase compared to previous year.

Compensation breakdown

Bonus$107,500
Salary$200,000
Stock Awards$587,600
Other$16,620
Total$911,720

Backenroth received $587.6K in stock awards, accounting for 64% of the total pay in 2016.

Backenroth also received $107.5K in bonus, $200K in salary and $16.6K in other compensation.

Rankings

In 2016, Sam Backenroth's compensation ranked 8,675th out of 14,075 executives tracked by ExecPay. In other words, Backenroth earned more than 38.4% of executives.

ClassificationRankingPercentile
All
8,675
out of 14,075
38th
Division
Manufacturing
3,348
out of 5,486
39th
Major group
Chemicals And Allied Products
1,138
out of 1,900
40th
Industry group
Drugs
894
out of 1,543
42nd
Industry
Pharmaceutical Preparations
710
out of 1,173
40th
Source: SEC filing on September 7, 2018.

Backenroth's colleagues

We found two more compensation records of executives who worked with Sam Backenroth at Ohr Pharmaceutical in 2016.

2016

Jason Slakter

Ohr Pharmaceutical

Chief Executive Officer

2016

Avner Ingerman

Ohr Pharmaceutical

Former Chief Clinical Officer

News

You may also like